From: The Directly Observed Therapy Short-Course (DOTS) strategy in Samara Oblast, Russian Federation
Drug | Beijing strain (n = 361) | Non-Beijing strain (n = 348) | OR (95%CI) | RR (95%CI) | RD (95%CI) | ||
---|---|---|---|---|---|---|---|
 | N resistant | % resistant (95%CI) | N resistant | % resistant (95%CI) |  |  |  |
Isoniazid* | 170 | 47.1 (48.0–52.3) | 53 | 15.2 (11.7–19.3) | 5.0 (3.5–7.1) | 3.1 (2.4–4.1) | 31.9 (25.2–38.5) |
Rifampicin* | 140 | 38.8 (33.9–43.9) | 41 | 11.8 (8.7–15.5) | 4.7 (3.2–7.0) | 3.3 (2.4–4.5) | 27.0 (20.7–33.3) |
MDR TB* | 127 | 35.2 (30.4–40.2) | 33 | 9.5 (6.7–12.9) | 5.2 (3.4–7.9) | 3.7 (2.6–5.3) | 25.7 (19.6–31.8) |
Streptomycin* | 144 | 39.9 (34.9–45.0) | 45 | 12.9 (9.7–16.8) | 4.5 (3.1–6.5) | 3.1 (2.3–4.2) | 27.0 (20.5–33.4) |
Ethambutol* | 89 | 24.7 (20.4–29.3) | 26 | 7.5 (5.0–10.6) | 4.1 (2.5–6.5) | 3.3 (2.2–5.0) | 17.2 (11.7–22.) |